MichaelHeifermanMD

Retinal Disease, Ocular Oncology

Assistant Professor of Ophthalmology and Visual Sciences Ophthalmology Residency Associate Program Director

Dr. Heiferman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
1009 S. Wood St., 5th Floor
Chicago, IL 60612
Phone+1 312-996-3937

Fax+1 312-996-7770

Dr. Michael Heiferman is an ophthalmologist in Chicago, IL and is affiliated with University of Illinois Hospital & Health Sciences System. He received his medical degree from Northwestern University and has been in practice 4 years. He specializes in retinal disease and ocular oncology. He has more than 20 publications and over 400 citings.

University of Illinois College of Medicine at ChicagoFellowship, Surgical Retina and Vitreous, 2019 - 2021
McGaw Medical Center of Northwestern UniversityResidency, Ophthalmology, 2016 - 2019
Northwestern University The Feinberg School of MedicineClass of 2015

PubMed

Automated segmentation for early detection of uveal melanoma.
Jiechao Ma, Sabrina P Iddir, Sanjay Ganesh, Darvin Yi, Michael J Heiferman
Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie. 2024-12-01
Colour fusion effect on deep learning classification of uveal melanoma.
Albert K Dadzie, Sabrina P Iddir, Mansour Abtahi, Behrouz Ebrahimi, David Le
Eye. 2024-10-01
OCTA-ReVA: an open-source toolbox for comprehensive retinal vessel feature analysis in optical coherence tomography angiography.
Albert K Dadzie, David Le, Mansour Abtahi, Behrouz Ebrahimi, Tobiloba Adejumo
Biomedical Optics Express. 2024-10-01

Oral Belzutifan Shows Efficacy in Ocular Von Hippel-Lindau DiseaseDecember 5th, 2024
First Liver-Directed Therapy for Metastatic Uveal Melanoma Is ApprovedApril 12th, 2024
Sociodemographic Factors May Be Related to Quality of Ocular Oncology CareJuly 17th, 2024